Skip to content

Biohaven BHVN Return on invested capital

Return on invested capital at other companies

Eli Lilly logo
Eli LillyLLY
42%+16.6pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-59.1%+48.1pp
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-38.2%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-67.6%+14.9pp
uniQure logo
uniQureQURE
-119%+424pp
Roivant Sciences logo
Roivant SciencesROIV
-25.6%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Calculated from Biohaven’s reported figures.

Based on trailing twelve months.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's return on invested capital?
Biohaven (BHVN) reported return on invested capital of -395.4% in Q1 2026.
How has Biohaven's return on invested capital changed year-over-year?
Biohaven's return on invested capital increased by 27.8% year-over-year, from -547.4% to -395.4%.
What is the long-term trend for Biohaven's return on invested capital?
Over 2 years (2023 to 2025), Biohaven's return on invested capital has grown at a 41.0% compound annual growth rate (CAGR), from -162.6% to -323.1%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.